The β-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians

European Journal of Pharmacology

Volumn 584, Issue 2-3, 2008, Pages 278-284

  Rawls, Scott M ^a   Cavallo, Federica ^b   Capasso, Anna ^b   Ding, Zhe ^a   Raffa, Robert B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

lactam antibiotic; (Meth)amphetamine; Benzodiazepine; Cocaine; Dependence; Planaria; Withdrawal

Indexed keywords

AMPHETAMINE; CEFTRIAXONE; CLORAZEPATE; COCAINE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; TURBELLARIA; WITHDRAWAL SYNDROME;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CLORAZEPATE DIPOTASSIUM; COCAINE; COCAINE-RELATED DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID TRANSPORTER 2; METHAMPHETAMINE; MODELS, ANIMAL; MOTOR ACTIVITY; PLANARIANS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 41249083786     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.018     Document Type: Article

References (45)

1. Algeri S., Carolei A., Ferretti P., Gallone C., Palladini G., and Venturini G. Effects of dopaminergic agents on monoamine levels and motor behaviour in Planaria. Comp. Biochem. Physiol. [Part C] 74 (1983) 27-29
2. Beghi E., Bendotti C., and Mennini T. Merits of a new drug trial for ALS?. Science 308 (2005) 632-633
3. Cebrià F., Kudome T., Nakazawa M., Mineta K., Ikeo K., Gojobori T., and Agata K. The expression of neural-specific genes reveals the structural and molecular complexity of the planarian central nervous system. Mech. Dev. 116 (2002) 199-204
4. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65 (2001) 1-105
5. Eriksson K.S., and Panula P. Gamma-aminobutyric acid in the nervous system of a planarian. J. Comp. Neurol. 345 (1994) 528-536
6. Fujio M., Nakagawa T., Sekiya Y., Ozawa T., Suzuki Y., Minami M., Satoh M., and Kaneko S. Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats. Eur. J. Neurosci. 22 (2005) 2744-2754
7. Kimmel H.D., and Garrigan H.A. Resistance to extinction in planaria. J. Exp. Psychol. 101 (1973) 343-347
8. Koyuncuoglu H., Gungor M., Sagduyu H., and Aricioglu F. Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats. Pharmacol. Biochem. Behav. 35 (1990) 829-832
9. Kusayama T., and Watanabe S. Reinforcing effects of methamphetamine in planarians. Neuroreport 11 (2000) 2511-2513
10. Lipski J., Wan C.K., Bai J.Z., Pi R., Li D., and Donnelly D. Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 146 (2007) 617-629
11. McGregor C., Srisurapanont M., Jittiwutikarn J., Laobhripatr S., Wongtan T., and White J.M. The nature, time course and severity of methamphetamine withdrawal. Addiction 100 (2005) 1320-1329
12. Miller T.M., and Cleveland D.W. Medicine. Treating neurodegenerative diseases with antibiotics. Science 307 (2005) 361-362 (2005)
13. Mitani A., and Tanaka K. Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 23 (2003) 7176-7182
14. Nakagawa T., and Satoh M. Involvement of glial glutamate transporters in morphine dependence. Ann. N. Y. Acad. Sci. 1025 (2004) 383-388
15. Newmark P.A., and Sanchez Alvarado A. Not your father's planarian: a classic model enters the era of functional genomics. Nat. Rev. Genet. 3 (2002) 210-219
16. Ozawa T., Nakagawa T., Shige K., Minami M., and Satoh M. Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal. Brain Res. 905 (2001) 254-258
17. Ozawa T., Nakagawa T., Sekiya Y., Minami M., and Satoh M. Effect of gene transfer of GLT-1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats. Eur. J. Neurosci. 19 (2004) 221-226
18. Palladini G., Ruggieri S., Stocchi F., De Pandis M.F., Venturini G., and Margotta V. A pharmacological study of cocaine activity in planaria. Comp. Biochem. Physiol. [Part C] 115 (1996) 41-45
19. Raffa R.B., and Valdez J.M. Cocaine withdrawal in Planaria. Eur. J. Pharmacol. 430 (2001) 143-145
20. Raffa R.B., and Desai P. Description and quantification of cocaine withdrawal signs in Planaria. Brain Res. 1032 (2005) 200-202
21. Raffa R.B., and Martley A.F. Amphetamine-induced increase in planarian locomotor activity and block by UV light. Brain Res. 1031 (2005) 138-140
22. Raffa R.B., Valdez J.M., Holland L.J., and Schulingkamp R.J. Energy-dependent UV light-induced disruption of (-)sulpiride antagonism of dopamine. Eor. J. Pharmacol. 406 (2000) R11-R12
23. Raffa R.B., Holland L.J., and Schulingkamp R.J. Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. Pharmacol. Toxicol. Methods 45 (2001) 223-226
24. Raffa R.B., Stagliano G.W., and Umeda S. k-Opioid withdrawal in Planaria. Neurosci. Lett. 349 (2003) 139-142
25. Raffa R.B., Stagliano G.W., and Tallarida R.J. Subadditive withdrawal from cocaine/k-opioid agonist combinations in Planaria. Brain Res. 1114 (2006) 31-35
26. Rao V.L., Dogan A., Todd K.G., Bowen K.K., Kim B.T., Rothstein J.D., and Dempsey R.J. Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain. J. Neurosci. 21 (2001) 1876-1883
27. Rasmussen K., Fuller R.W., Stockton M.E., Perry K.W., Swinford R.M., and Ornstein P.L. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. Eur. J. Pharmacol. 197 (1991) 9-16
28. Rawls S.M., Gomez T., Stagliano G.W., and Raffa R.B. Measurement of glutamate and aspartate in Planaria. J. Pharmacol. Toxicol. Meth. 53 (2006) 291-295
29. Rawls S.M., Rodriguez T., Baron D.A., and Raffa R.B. A nitric oxide synthase inhibitor (L-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria. Brain Res. 1099 (2006) 82-87
30. Rawls S.M., Gomez T., and Raffa R.B. An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2). Pharmacol. Biochem. Behav 86 (2007) 499-504
31. Rawls S.M., Tallarida R., Robinson W., and Amin M. The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats. Brit. J. Pharmacol. 151 (2007) 1095-1102
32. Rothstein J.D. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin. Neurosci. 3 (1995-1996) 348-359
33. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., and Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38 (1995) 73-84
34. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Hoberg M.D., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.-z., Gupta P., and Fisher P.B. β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433 (2005) 73-77 (2005)
35. Rumbaugh J.A., Li G., Rothstein J., and Nath A. Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins. J. Neurovirol. 13 (2007) 168-172
36. Secko D. Antibiotics that protect the brain. Canad. Med. Assoc. J. 172 (2005) 467-468
37. Segal D.S., and Kuczenski R. Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance. Neuropsychopharmacol 31 (2006) 941-955
38. Segal D.S., Kuczenski R., O'Neil M.L., Melega W.P., and Cho A.K. Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization. Psychopharmacology (Berlin) 180 (2006) 501-512
39. Sepkuty J.P., Cohen A.S., Eccles C., Rafiq A., Behar K., Ganel R., Coulter D.A., and Rothstein J.D. A neuronal glutamate transporter contributes to neurotransmitter GABA synthesis and epilepsy. J. Neurosci. 22 (2002) 6372-6379
40. Tanganelli S., Antonelli T., Morari M., Bianchi C., and Beani L. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci. Lett. 122 (1991) 270-272
41. Tokuyama S., Wakabayashi H., and Ho I.K. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur. J. Pharmacol. 295 (1996) 123-129
42. Umeda S., Stagliano G.W., and Raffa R.B. Cocaine and k-opioid withdrawal in Planaria blocked by d-, but not l-, glucose. Brain Res. 1018 (2004) 181-185
43. Venturini G., Stocchi F., Margotta V., Ruggieri S., Bravi D., Bellantuono P., and Palladini G. A pharmacological study of dopaminergic receptor in planaria. Neuropharmacology 28 (1989) 1377-1382
44. Ye Z.C., Rothstein J.D., and Sontheimer H. Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J. Neurosci. 19 (1999) 10767-10777
45. Zhu H., and Barr G.A. Opiate withdrawal during development: are NMDA receptors indispensable?. Trends Pharmacol. Sci. 22 (2001) 404-408